Memantine for moderate and severe Alzheimer's disease: systematic review and meta-analysis

被引：0
|
作者：
Minakaran, N. [1 ]
McShane, R. [2 ]
Sastre, A. Areosa [3 ]
机构：
[1] Univ London St Georges Hosp, London, England
[2] Univ Oxford, Cochrane Dementia & Cognit Improvement Grp, Oxford OX1 2JD, England
[3] Hosp La Ribera, Valencia, Spain
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2008年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：34 / 34
页数：1
相关论文
共 50 条
  • [1] Systematic review and meta-analysis of cholinesterase inhibitors and memantine for moderate to severe Alzheimer's disease
    Schneider, Lon S.
    Dagerman, Karen
    Shaikh, Zakaria
    McShane, Rupert
    [J]. NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S71 - S71
  • [2] Memantine Monotherapy for Alzheimer's Disease: A Systematic Review and Meta-Analysis
    Matsunaga, Shinji
    Kishi, Taro
    Iwata, Nakao
    [J]. PLOS ONE, 2015, 10 (04):
  • [3] Memantine for Alzheimer's Disease: An Updated Systematic Review and Meta-analysis
    Kishi, Taro
    Matsunaga, Shinji
    Oya, Kazuto
    Nomura, Ikuo
    Ikuta, Toshikazu
    Iwata, Nakao
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2017, 60 (02) : 401 - 425
  • [4] Memantine Monotherapy for Alzheimer's Disease: A Systematic Review and Meta-analysis
    Matsunaga, Shinji
    Kishi, Taro
    Iwata, Nakao
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 264 - 264
  • [5] Acetylcholinesterase inhibitors combined with memantine for moderate to severe Alzheimer's disease: a meta-analysis
    Dominik, Glinz
    Viktoria, Gloy L.
    Andreas, Monsch U.
    Reto, Kressig W.
    Chandni, Patel
    Alba, McCord Kimberly
    Zanfina, Ademi
    Yuki, Tomonaga
    Matthias, Schwenkglenks
    Heiner, Bucher C.
    Heike, Raatz
    [J]. SWISS MEDICAL WEEKLY, 2019, 149
  • [6] Memantine in moderate to severe Alzheimer's disease:: a meta-analysis of randomised clinical trials
    Winblad, Bengt
    Jones, Roy W.
    Wirth, Yvonne
    Stoffler, Albrecht
    Mobius, Hans Jorg
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2007, 24 (01) : 20 - 27
  • [7] Meta-analysis of clinical trial data with memantine in moderate to severe Alzheimer's disease
    Winblad, B.
    Jones, R. W.
    Wirth, Y.
    Stoeffler, A.
    Moebius, H. J.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 71 - 71
  • [8] Memantine is safe and effective in the treatment of moderate to severe Alzheimer's disease: An updated meta-analysis
    Olin, J. T.
    Graham, S. M.
    Resnick, E. M.
    Tocco, M.
    Perhach, J.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 54 - 54
  • [9] Memantine in moderate to severe Alzheimer’s disease
    Andrew Kertesz
    [J]. Current Neurology and Neuroscience Reports, 2003, 3 (6) : 485 - 486
  • [10] Combination Therapy with Cholinesterase Inhibitors and Memantine for Alzheimer's Disease: A Systematic Review and Meta-Analysis
    Matsunaga, Shinji
    Kishi, Taro
    Iwata, Nakao
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2015, 18 (05): : 1 - 11
12345